Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study

Challenges in the Diagnosis of the Antiphospholipid Syndrome

(2010) K. Devreese et al.   CLINICAL CHEMISTRY

Update on anti-phospholipid antibodies in SLE: the Hopkins’ Lupus Cohort

(2010) M. Petri   LUPUS

Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice

(2010) RAS Roubey   LUPUS

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus

(2010) M. B. Urowitz et al.   ARTHRITIS CARE & RESEARCH

A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus

(2009) E. Svenungsson et al.   ANNALS OF THE RHEUMATIC DISEASES

Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the nurses' health study

(2009) A. Elisabeth Hak et al.   ARTHRITIS AND RHEUMATISM

Risk Factors for Development of Coronary Artery Disease in Women with Systemic Lupus Erythematosus

(2009) R. J. GOLDBERG et al.   JOURNAL OF RHEUMATOLOGY

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

(2009) Johanna Gustafsson et al.   ARTHRITIS RESEARCH & THERAPY

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

(2008) G Ruiz-Irastorza et al.   ANNALS OF THE RHEUMATIC DISEASES

Arteriosclerosis obliterans associated with anti-cardiolipin antibody /  2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus

(2008) J. Nojima et al.   RHEUMATOLOGY